Back to Journals » OncoTargets and Therapy » Volume 12

RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis

Total article views   HTML views PDF downloads Totals
5,380 Dovepress* 5,088+ 870 5,958
PubMed Central* 292 99 391
Totals 5,380 969 6,349
*Since 20 December 2018

View citations on PubMed Central and Google Scholar